Guthart Gary S - Jul 28, 2023 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role
CEO, Director
Signature
By: Donna Spinola For: Guthart, Gary S
Stock symbol
ISRG
Transactions as of
Jul 28, 2023
Transactions value $
-$15,179,171
Form type
4
Date filed
8/1/2023, 04:47 PM
Previous filing
May 31, 2023
Next filing
Aug 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $2.88M +67.5K $42.64* 67.5K Jul 28, 2023 Direct F1
transaction ISRG Common Stock Sale -$16.4M -50.3K -74.54% $326.76 17.2K Jul 28, 2023 Direct F1, F2
transaction ISRG Common Stock Gift $0 -16K -1.34% $0.00 1.18M Jul 28, 2023 by Trust F3
transaction ISRG Common Stock Sale -$808K -2.48K -7.13% $325.89 32.3K Jul 31, 2023 by Trust FBO Daughte F1
transaction ISRG Common Stock Sale -$808K -2.48K -7.13% $325.89 32.3K Jul 31, 2023 by Trust FBO Son F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -67.5K -100% $0.00* 0 Jul 28, 2023 Common Stock 67.5K $42.64 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 29, 2024.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $325.13 to $328.45 as follows: 8,061 shares sold at $325.13 to $326.10; 26,670 shares sold at $326.14 to $327.12; 14,483 shares sold at $327.15 to $327.95; and 1,100 shares sold at $328.34 to $328.45. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 The shares were donated to a Donor Advised Fund (DAF) in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 29, 2024.
F4 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.